BRIDGEWATER, N.J.--(BUSINESS WIRE)--Insmed Incorporated (NASDAQ:INSM) today announced that on March 26, 2015, it approved non-statutory stock options to purchase 100,000 shares of its common stock to Dr. Eugene Sullivan, the Company’s Chief Medical and Scientific Officer and, in addition, approved non-statutory stock options to purchase an aggregate of 27,000 shares of its common stock to two new employees. The awards were made pursuant to the NASDAQ inducement grant exception as a component of these new hires’ employment compensation in connection with the Company’s equity grant program.
Help employers find you! Check out all the jobs and post your resume.
